Ono Pharmaceutical News

Ono Pharmaceutical: Announcements of individual stocks regarding the completion of payment for disposal of treasury stock as transfer restriction stock compensation with continuance employment and transfer restriction stock compensation linked to performance.

Jul 11 23:00 ET

Ono Pharmaceutical: [Postponed] Corporate Governance Report

Jul 4 03:00 ET

Ono Pharmaceutical: Report on Corporate Governance June 27, 2024.

Jun 27 03:20 ET

Ono Pharmaceutical: Extraordinary Report

Jun 20 20:05 ET

Ono Pharmaceutical: Internal Control Report - 76th Period (2023/04/01 - 2024/03/31)

Jun 20 20:04 ET

Ono Pharmaceutical: Confirmation letter

Jun 20 20:03 ET

Ono Pharmaceutical: Securities Report - 76th Fiscal Year (April 1, 2023 - March 31, 2024)

Jun 20 20:02 ET

Ono Pharmaceutical: Announcements of individual stocks regarding disposal of treasury stock as share-based compensation with continuous transfer restrictions and share-based compensation with performance-based transfer restrictions.

Jun 20 03:30 ET

Ono Pharmaceutical: Extraordinary Report

Jun 20 03:00 ET

Ono Pharmaceutical: Announcements of individual stocks regarding the results of the public tender offer for shares of Deciphera Pharmaceuticals, Inc. in the USA and acquisition completion (total subsidiaryization).

Jun 11 08:30 ET

Ono Pharmaceutical: Notice of the 2024 Convocation Annual General Meeting

May 22 19:00 ET

Ono Pharmaceutical: 2024 Annual General Meeting of Shareholders Materials (Issued Documents Omitted)

May 22 19:00 ET

Ono Pharmaceutical: 2024 Annual General Shareholders' Meeting Convocation Notice and Shareholders' Meeting Materials

May 22 19:00 ET

Ono Pharmaceutical: Independent Officer Notification Form

May 22 02:30 ET

Ono Pharmaceutical: Extraordinary Report

May 12 22:59 ET

Ono Pharmaceutical: Notice regarding differences between individual results and previous fiscal year results

May 8 23:00 ET

Ono Pharmaceutical: Supplemental Financial Results for the Fiscal Year Ending March 31, 2012 (Consolidated IFRS)

May 8 23:00 ET

Ono Pharmaceutical: Summary of financial results for the fiscal year ending 2024/3 [IFRS] (consolidated)

May 8 23:00 ET

Ono Pharmaceutical: Notice regarding the conclusion of an agreement to acquire Deciphera Pharmaceuticals in the United States

Apr 29 19:00 ET

Ono Pharmaceutical: Stock Purchase Status Report (based on Section 24-6 (1) of the Act)

Apr 12 02:00 ET